Sarvas is a health tech company focused on predicting the risk of onset of chronic disease using an AI foundation model and primary care electronic health records. Their launch product, SarvasHF, identifies patients at risk of developing heart failure within a five-year window, enabling earlier testing and intervention in primary care, where symptoms often first appear, but are currently underdiagnosed.